Skip to Content
Merck
  • GITR Agonism Triggers Antitumor Immune Responses through IL21-Expressing Follicular Helper T Cells.

GITR Agonism Triggers Antitumor Immune Responses through IL21-Expressing Follicular Helper T Cells.

Cancer immunology research (2020-03-04)
Choong-Hyun Koh, Il-Kyu Kim, Kwang-Soo Shin, Insu Jeon, Boyeong Song, Jeong-Mi Lee, Eun-Ah Bae, Hyungseok Seo, Tae-Seung Kang, Byung-Seok Kim, Yeonseok Chung, Chang-Yuil Kang
ABSTRACT

Although treatment with the glucocorticoid-induced tumor necrosis factor receptor-related protein (GITR) agonistic antibody (DTA-1) has shown antitumor activity in various tumor models, the underlying mechanism is not fully understood. Here, we demonstrate that interleukin (IL)-21-producing follicular helper T (Tfh) cells play a crucial role in DTA-1-induced tumor inhibition. The administration of DTA-1 increased IL21 expression by Tfh cells in an antigen-specific manner, and this activation led to enhanced antitumor cytotoxic T lymphocyte (CTL) activity. Mice treated with an antibody that neutralizes the IL21 receptor exhibited decreased antitumor activity when treated with DTA-1. Tumor growth inhibition by DTA-1 was abrogated in Bcl6fl/flCd4Cre mice, which are genetically deficient in Tfh cells. IL4 was required for optimal induction of IL21-expressing Tfh cells by GITR costimulation, and c-Maf mediated this pathway. Thus, our findings identify GITR costimulation as an inducer of IL21-expressing Tfh cells and provide a mechanism for the antitumor activity of GITR agonism.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Human IL21 / Interleukin-21 ELISA Kit
Sigma-Aldrich
RIPA Buffer
Sigma-Aldrich
BCL6 Inhibitor, 79-6, The BCL6 Inhibitor, 79-6 controls the biological activity of BCL6. This small molecule/inhibitor is primarily used for Cancer applications.